CRC
MRK icon

Curi RMB Capital’s Merck MRK Stock Holding History

Curi RMB Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.7M Buy
443,638
+416
+0.1% +$48K 0.96% 16
2025
Q4 		$47M Buy
443,222
+52,799
+14% +$4.96M 0.81% 24
2025
Q3 		$33M Sell
390,423
-2,365
-0.6% -$195K 0.61% 35
2025
Q2 		$31.3M Buy
392,788
+65,987
+20% +$5.25M 0.59% 36
2025
Q1 		$29.5M Buy
326,801
+114,757
+54% +$10.7M 0.73% 31
2024
Q4 		$21.1M Buy
212,044
+14,562
+7% +$1.5M 0.49% 49
2024
Q3 		$22.4M Sell
197,482
-22,942
-10% -$2.73M 0.51% 52
2024
Q2 		$27.3M Sell
220,424
-7,735
-3% -$996K 0.65% 37
2024
Q1 		$30.1M Buy
228,159
+82,643
+57% +$10.2M 0.69% 37
2023
Q4 		$15.9M Buy
145,516
+9,464
+7% +$982K 0.48% 62
2023
Q3 		$14M Buy
136,052
+9,958
+8% +$1.07M 0.48% 68
2023
Q2 		$14.6M Buy
126,094
+6,674
+6% +$758K 0.48% 66
2023
Q1 		$12.7M Buy
119,420
+21,377
+22% +$2.31M 0.44% 73
2022
Q4 		$10.9M Buy
98,043
+20,309
+26% +$2.08M 0.39% 87
2022
Q3 		$6.69M Buy
77,734
+24,434
+46% +$2.18M 0.25% 111
2022
Q2 		$4.86M Buy
53,300
+8,258
+18% +$732K 0.17% 133
2022
Q1 		$3.7M Buy
45,042
+4,103
+10% +$323K 0.12% 153
2021
Q4 		$3.14M Buy
40,939
+1,398
+4% +$111K 0.09% 165
2021
Q3 		$2.97M Buy
39,541
+2
+0% +$152 0.1% 165
2021
Q2 		$3.08M Buy
39,539
+4,477
+13% +$333K 0.1% 163
2021
Q1 		$2.58M Buy
35,062
+4,828
+16% +$356K 0.1% 167
2020
Q4 		$2.36M Buy
30,234
+8,643
+40% +$661K 0.09% 197
2020
Q3 		$1.71M Buy
21,591
+4,355
+25% +$341K 0.07% 213
2020
Q2 		$1.27M Sell
17,236
-38,260
-69% -$2.88M 0.06% 265
2020
Q1 		$4.07M Buy
55,496
+1,885
+4% +$148K 0.19% 123
2019
Q4 		$4.65M Sell
53,611
-530
-1% -$43.5K 0.13% 178
2019
Q3 		$4.35M Sell
54,141
-13,039
-19% -$1.04M 0.11% 190
2019
Q2 		$5.38M Sell
67,180
-29,717
-31% -$2.28M 0.14% 169
2019
Q1 		$7.69M Buy
96,897
+1,404
+1% +$105K 0.19% 139
2018
Q4 		$6.96M Buy
95,493
+7,176
+8% +$507K 0.18% 143
2018
Q3 		$5.98M Sell
88,317
-11,743
-12% -$748K 0.14% 180
2018
Q2 		$5.79M Buy
100,060
+75,342
+305% +$4.25M 0.14% 185
2018
Q1 		$1.28M Sell
24,718
-15,047
-38% -$813K 0.03% 466
2017
Q4 		$2.13M Buy
39,765
+9,784
+33% +$542K 0.06% 364
2017
Q3 		$1.83M Sell
29,981
-322
-1% -$19.5K 0.05% 372
2017
Q2 		$1.85M Buy
30,303
+223
+0.7% +$13.6K 0.05% 379
2017
Q1 		$1.82M Buy
30,080
+5,069
+20% +$308K 0.08% 237
2016
Q4 		$1.41M Buy
25,011
+20,332
+435% +$1.19M 0.08% 214
2016
Q3 		$279K Buy
4,679
+271
+6% +$15.8K 0.02% 352
2016
Q2 		$242K Buy
4,408
+173
+4% +$9.21K 0.01% 381
2016
Q1 		$214K Buy
+4,235
New +$207K 0.01% 337

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Curi RMB Capital's MRK Position: Q1 2026 in Review

Curi RMB Capital increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $48K and bringing the position to 443,638 shares worth $53.7M. The position accounts for 0.96% of the portfolio, ranked #16.

Curi RMB Capital first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Curi RMB Capital held 443,638 shares of Merck worth $53.7M as of Q1 2026.
  • Curi RMB Capital bought 416 Merck shares in Q1 2026, an estimated $48K.
  • Merck made up 0.96% of Curi RMB Capital's portfolio in Q1 2026, its #16 holding.
  • Curi RMB Capital first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.